In a study employing genetically engineered high-affinity natural killer (haNK) cells, PD-L1-targeted CAR haNKs effectively inhibited tumor growth in a PD-L1-dependent manner and concurrently depleted myeloid cell populations that endogenously express high levels of PD-L1 [36]. Here, CD274 is linked to neoplasm.